Innovative Pharmaceutical Biotech Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Innovative Pharmaceutical Biotech Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -68.18% vs -18.52% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -677.81% vs 138.75% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.10",
          "val2": "6.60",
          "chgp": "-68.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-13.30",
          "val2": "-12.50",
          "chgp": "-6.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "260.10",
          "val2": "218.10",
          "chgp": "19.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-297.00",
          "val2": "330.20",
          "chgp": "-189.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-570.30",
          "val2": "98.70",
          "chgp": "-677.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6,342.90%",
          "val2": "-2,037.60%",
          "chgp": "-430.53%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

2.10

6.60

-68.18%

Operating Profit (PBDIT) excl Other Income

-13.30

-12.50

-6.40%

Interest

260.10

218.10

19.26%

Exceptional Items

-297.00

330.20

-189.95%

Consolidate Net Profit

-570.30

98.70

-677.81%

Operating Profit Margin (Excl OI)

-6,342.90%

-2,037.60%

-430.53%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is -68.18% vs -18.52% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -677.81% vs 138.75% in Mar 2024

All Annual Results